15
3080 (w), 2947 (w), 2835 (w), 1703 (s) cm-1. HRMS (EI) m/z:
(d, J = 8.2 Hz, 1.13 H), 7.66 (d, J = 8.2 Hz, 1.12 H), 7.56 -
ACCEPTED MANUSCRIPT
[M]+ Calcd. for C16H14O3S 286.0664; Found 286.0663.
7.50 (m, 1.07 H), 7.48 (d, J = 4.9 Hz, 0.40 H), 7.43 (ddd, J = 1.2,
6.7, 7.9 Hz, 1.32 H), 7.36 (ddd, J = 1.2, 6.7, 8.2 Hz, 1.20 H), 7.33
- 7.31 (m, 0.21 H), 7.18 (dd, J = 1.4, 2.9 Hz, 1.01 H), 7.13 (dd, J
= 3.1, 4.9 Hz, 1.01 H), 7.01 (dd, J = 1.8, 8.5 Hz, 0.06 H), 6.90 -
6.89 (m, 0.04 H), 6.87 (dd, J = 1.4, 5.0 Hz, 0.04 H), 6.64 (dd, J =
1.4, 5.0 Hz, 0.98 H), 5.39 (d, J = 1.8 Hz, 1.00 H), 5.06 - 5.04 (m,
0.04 H), 3.96 (s, 0.34 H), 3.81 (s, 0.73 H), 3.78 (s, 2.96 H), 3.72
(s, 0.97 H), 3.71 (s, 0.51 H), 3.66 (s, 0.13 H) 13C NMR (126
MHz, CDCl3) δ = 165.0, 164.4, 150.2, 148.8, 147.4, 146.0, 142.9,
141.5, 140.9, 139.0, 138.9, 137.5, 133.5, 133.4, 133.2, 132.9,
131.8, 130.4, 129.6, 129.4, 129.1, 128.8, 128.8, 128.4, 128.2,
127.8, 127.7, 127.5, 127.1, 126.8, 126.6, 126.2, 126.2, 126.0,
125.7, 125.3, 125.2, 124.0, 123.3, 122.8, 122.7, 122.2, 121.2,
51.5, 51.3, 51.2, 50.5, 39.9, 37.2. IR: 3103 (w), 3055 (w), 2947
(w), 2843 (w), 1703 (s) cm-1. HRMS (EI) m/z: [M]+ Calcd. for
C19H14O2S 306.0715; Found 306.0713.
Methyl
5-methoxy-1-(thiophen-3-yl)-1H-indene-2-carboxylate
(5ag-IV)
The general procedure F was followed using allylic alcohol
4ag (78 mg, 0.256 mmol) in benzene (5.1 mL), Ca(NTf2)2 (15.4
mg, 0.026 mmol), n-Bu4NPF6 (9.9 mg, 0.026 mmol). After work
up and purification, (20% EtOAc/Hexanes, Rf = 0.545),
compound 5ag-IV was afforded as an off-white solid (58.2 mg,
1
79% yield). [m.p. = 101-119 ˚C] H NMR (500 MHz, CDCl3)
δ = 7.69 (d, J = 1.8 Hz, 1 H), 7.19 (d, J = 8.2 Hz, 1 H), 7.17 (dd,
J = 2.9, 5.0 Hz, 1 H), 7.13 (dd, J = 1.1, 2.9 Hz, 1 H), 7.05 (d, J =
2.4 Hz, 1 H), 6.87 (dd, J = 2.4, 8.2 Hz, 1 H), 6.69 (dd, J = 1.4,
5.0 Hz, 1 H), 4.98 (d, J = 1.8 Hz, 1 H), 3.84 (s, 3 H), 3.74 (s, 3 H)
13C NMR (126 MHz, CDCl3) δ = 164.6, 159.3, 142.2, 141.8,
141.5, 140.9, 138.1, 126.7, 125.3, 124.9, 121.8, 114.6, 108.3,
55.4, 51.5, 49.9. IR: 3103 (w), 2949 (w), 2835 (w), 1705 (s) cm-
1. HRMS (EI) m/z: [M]+ Calcd. for C16H14O3S 286.0664; Found
286.0662.
Methyl
carboxylate (5ba-I)
3-phenyl-1H-benzo[b]cyclopenta[d]thiophene-2-
The general procedure was followed using allylic alcohol 4ba
(54 mg, 0.167 mmol) in benzene (3.3 mL), Ca(NTf2)2 (10 mg,
0.017 mmol), n-Bu4NPF6 (6.5 mg, 0.017 mmol). After work up
and purification, (25% EtOAc/Hexanes, Rf = 0.673), compound
5ba-I was afforded as a yellow solid (26.8 mg, 53% yield). [m.p.
= 104-113 ˚C] 1H NMR (500 MHz, CDCl3) δ = 7.81 - 7.86 (m, 2
H), 7.71 (dd, J = 7.93, 1.53 Hz, 2 H), 7.40 - 7.52 (m, 4 H), 7.31 -
7.36 (m, 1 H), 3.96 (s, 2 H), 3.76 (s, 3 H). 13C NMR (126 MHz,
CDCl3) δ = 164.7, 150.8, 146.9, 144.6, 143.7, 134.4, 133.8,
130.0, 129.0, 128.8, 128.0, 124.9, 124.5, 123.8, 121.8, 51.3, 36.9.
IR: 3057 (w), 2949 (w), 2845 (w), 1701 (s) cm-1. HRMS (EI)
m/z: [M]+ Calcd. for C19H14O2S 306.0715; Found 306.0708.
Methyl
carboxylate (5ah-I)
6-(thiophen-2-yl)-4H-cyclopenta[b]thiophene-5-
The general procedure F was followed using allylic alcohol
4ah (71 mg, 0.255 mmol) in benzene (5.1 mL), Ca(NTf2)2 (15.3
mg, 0.026 mmol), n-Bu4NPF6 (9.9 mg, 0.026 mmol). After work
up and purification, (20% EtOAc/Hexanes, Rf = 0.692),
compound 5ah-I was afforded as a reddish-brown oil (44.2 mg,
1
66% yield). H NMR (500 MHz, CDCl3) δ = 7.99 (d, J = 3.66
Hz, 1 H) 7.51 (d, J = 5.19 Hz, 1 H), 7.47 (dd, J = 4.88, 0.61 Hz, 1
H), 7.15 - 7.19 (m, 1 H), 7.11 (d, J = 4.88 Hz, 1 H), 3.82 (d, J =
0.61 Hz, 3 H), 3.75 (s, 2 H). 13C NMR (126 MHz, CDCl3) δ =
164.9, 148.7, 146.0, 142.1, 134.9, 131.0, 130.4, 128.6, 127.3,
126.9, 122.3, 51.3, 37.3. IR: 3099 (w), 2945 (w), 1692 (s) cm-1.
HRMS (EI) m/z: [M]+ Calcd. for C13H10O2S2 262.0122; Found
262.0127.
Methyl
1-phenyl-1H-cyclopenta[b]naphthalene-2-carboxylate
(5da-II)
The general procedure F was followed using allylic alcohol
4da (99 mg, 0.311 mmol) in benzene (6.2 mL), Ca(NTf2)2 (18.7
mg, 0.031 mmol), n-Bu4NPF6 (12.0 mg, 0.031 mmol). After
work up and purification, (15% EtOAc/Hexanes, Rf = 0.404),
compound 5da-II was afforded as a white solid (69.6 mg, 75%
yield). [m.p. = 145-147 ˚C] 1H NMR (500 MHz, CDCl3) δ = 7.90
(d, J = 8.24 Hz, 2 H) 7.88 (d, J = 1.83 Hz, 1 H) 7.70 (d, J = 8.54
Hz, 2 H) 7.43 (ddd, J = 8.16, 6.79, 1.22 Hz, 1 H) 7.35 (ddd, J =
8.32, 6.94, 1.22 Hz, 1 H) 7.21 - 7.30 (m, 3 H) 7.16 - 7.19 (m, 2
H) 5.22 (d, J = 1.83 Hz, 1 H) 3.77 (s, 3 H). 13C NMR (126 MHz,
CDCl3) δ = 164.3, 146.9, 142.7, 141.1, 139.4, 138.1, 133.5,
129.3, 128.8, 128.7, 128.5, 128.4, 126.8, 126.6, 125.9, 123.9,
121.1, 55.6, 51.4. IR: 3055 (w), 3026 (w), 2949 (w), 1705 (s) cm-
1. HRMS (EI) m/z: [M]+ Calcd. for C21H16O2 300.1150; Found
300.1148.
Methyl
(5ai-I)
(E)-6-styryl-4H-cyclopenta[b]thiophene-5-carboxylate
The general procedure F was followed using allylic alcohol
4ai (45.8 mg, 0.153 mmol) in benzene (3.1 mL), Ca(NTf2)2 (9.2
mg, 0.015 mmol), n-Bu4NPF6 (5.9 mg, 0.015 mmol). After work
up and purification, (15% EtOAc/Hexanes, Rf = 0.411),
compound 5ai-I was afforded as a yellow solid (9.4 mg, 22%
1
yield). [m.p. = 96-101 ˚C] H NMR (500 MHz, CDCl3) δ = 8.29
(d, J = 16.48 Hz, 1 H) 7.65 (d, J = 7.63 Hz, 2 H) 7.50 (d, J = 4.88
Hz, 1 H) 7.37 - 7.42 (m, 3 H) 7.33 - 7.35 (m, 1 H) 7.13 (d, J =
4.88 Hz, 1 H) 3.86 (s, 3 H) 3.68 (s, 2 H). 13C NMR (126 MHz,
CDCl3) δ = 165.5, 149.2, 147.4, 142.2, 136.6, 136.5, 130.2,
130.1, 128.9, 128.8, 127.4, 122.1, 121.3, 51.3, 36.5. IR: 3059
(w), 3024 (w), 2949 (w), 2845 (w), 1690 (s) cm-1. HRMS (EI)
m/z: [M]+ Calcd. for C17H14O2S 282.0715; Found 282.0718.
Methyl 5-methoxy-1-phenyl-1H-indene-2-carboxylate (5ea-II)
The general procedure F was followed using allylic alcohol
4ea (73 mg, 0.245 mmol) in benzene (4.9 mL), Ca(NTf2)2 (14.7
mg, 0.024 mmol), n-Bu4NPF6 (9.5 mg, 0.024 mmol). After work
up and purification, (15% EtOAc/Hexanes, Rf = 0.320),
compound 5ea-II was afforded as an off-white solid (52.6 mg,
Methyl
carboxylate (5aj)
6-(naphthalen-2-yl)-6H-cyclopenta[b]thiophene-5-
The general procedure F was followed using allylic alcohol
4aj (27.4 mg, 0.085 mmol) in benzene (1.7 mL), Ca(NTf2)2 (5.1
mg, 0.008 mmol), n-Bu4NPF6 (3.3 mg, 0.008 mmol). After work
up and purification, (20% EtOAc/Hexanes, Rf = 0.48), a four
compound isomeric mixture was afforded as a reddish-brown oil
(18.4 mg, 71% yield). (Isomeric Ratio = 20 : 7.0 : 3.5: 1; Alkene
ratio = 2.0:1 trisubstituted (5aj-II/5aj-IV) to tetrasubstituted
(5aj-I/5aj-III)) H NMR (500 MHz, CDCl3) δ = 8.17 (s, .36 H),
7.94 - 7.89 (m, 1.21 H), 7.87 (dd, J = 4.9, 8.2 Hz, 2.56 H), 7.80
(d, J = 1.8 Hz, 1.02 H), 7.75 (dd, J = 1.8, 8.5 Hz, 0.49 H), 7.71
1
77% yield). [m.p. = 131-137 ˚C] H NMR (500 MHz, CDCl3) δ
= 7.77 (d, J = 1.8 Hz, 1 H), 7.30 - 7.23 (m, 3 H), 7.15 - 7.08 (m, 4
H), 6.87 (dd, J = 2.4, 8.2 Hz, 1 H), 4.84 (d, J = 1.8 Hz, 1 H), 3.86
(s, 3 H), 3.73 (s, 3 H) 13C NMR (126 MHz, CDCl3) δ = 164.6,
159.3, 142.8, 142.6, 142.4, 141.4, 138.6, 128.5, 127.8, 126.8,
125.0, 114.7, 108.2, 55.5, 54.9, 51.5. IR: 3028 (w), 2953 (w),
2835 (w), 1707 (s) cm-1. HRMS (EI) m/z: [M]+ Calcd. for
C18H16O3 280.1099; Found 280.1098.
1